Cargando…
Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
Follow-up of low-risk monoclonal gammopathy of undetermined significance (MGUS) is debated as multiple myeloma (MM) progression risk is low. Worse MM outcome was reported for patients followed for low-risk MGUS, possibly due to less optimal follow-up. However, it is unknown whether progressing low-r...
Autores principales: | Tahiru, Widad, Izarra Santamaria, Antonio, Hultdin, Johan, Wu, Wendy Yi-Ying, Späth, Florentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867673/ https://www.ncbi.nlm.nih.gov/pubmed/35197127 http://dx.doi.org/10.1186/s40164-022-00259-0 |
Ejemplares similares
-
Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
por: Şahver İşgör, İrem, et al.
Publicado: (2022) -
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016) -
Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008) -
Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019) -
Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021)